Sangui Bio Tech International Inc.

WITTEN, Germany, December 12, 2011 - Sangui enters commercialization phase / Initial order of Sangui developed wound spray The Mexican State of Tamaulipas has issued an initial order of Hemo2Spray, the Sangui developed wound spray, as well as of the wound debridement product Scabremove both registered by the Mexican authorities in September this year.

WITTEN, Germany, September 19, 2011 - Official registration as medical device granted / State of Tamaulipas indicates plans to start treatment in 22 hospitals The Mexican Commission for the Authorization of Pharmaceuticals and Medical Devices officially registered the entire current range of Sangui developed wound management products as medical devices and granted permission to use this treatment on a nationwide basis.